S100B transgenic mice develop features of Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archives of Medical Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.arcmed.2011.01.005PMID 21376255
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell-specific roles of GRK2 in onset and severity of hypoxic-ischemic brain damage in neonatal mice.

  2010cited by this paper
• G Protein-coupled Receptor Kinase-2 Constitutively Regulates D2 Dopamine Receptor Expression and Signaling Independently of Receptor Phosphorylation*

  2009cited by this paper
• La protéine S100β, premier marqueur biologique pour le diagnostic du traumatisme crânien mineur ou modéré

  2009cited by this paper
• [S100B protein: a novel biomarker for the diagnosis of head injury].

  2009cited by this paper
• S100B's double life: intracellular regulator and extracellular signal.

  2009cited by this paper
• Distinct regulation of brain-derived neurotrophic factor and noradrenaline in S100B knockout mice.

  2008cited by this paper
• Low Endogenous G-Protein-Coupled Receptor Kinase 2 Sensitizes the Immature Brain to Hypoxia–Ischemia-Induced Gray and White Matter Damage

  2008cited by this paper
• Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias.

  2008cited by this paper
• Protein-Protein Interactions and Dopamine D2 Receptor Signaling: A Calcium Connection

  2008cited by this paper
• S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells

  2008cited by this paper
• Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia.

  2008cited by this paper
• Altered expression and subcellular distribution of GRK subtypes in the dopamine‐depleted rat basal ganglia is not normalized by l‐DOPA treatment

  2008cited by this paper
• Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.

  2007cited by this paper
• Immune reactivity towards insulin, its amyloid and protein S100B in blood sera of Parkinson's disease patients

  2007cited by this paper
• S100B in neuropathologic states: The CRP of the brain?

  2007cited by this paper
• The Role of G-Protein-Coupled Receptor Kinase 5 in Pathogenesis of Sporadic Parkinson's Disease

  2006cited by this paper
• Time dependent alterations of co-localization of S100β and GFAP in the MPTP-treated mice

  2006cited by this paper
• Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-like gene-1 signaling pathway via the activation of dopamine receptors

  2005cited by this paper
• [Increased subthalamic neuronal activity after dorsal raphe nucleus lesion by 5,7-dihydroxytryptamine in the rat].

  2005cited by this paper
• S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage

  2005cited by this paper
• S100B and NSE serum levels in patients with Parkinson's disease.

  2005cited by this paper
• SURVIVAL AND MIGRATION OF TRANSPLANTED NEURAL STEM CELL-DERIVED DOPAMINE CELLS IN THE BRAIN OF PARKINSONIAN RAT

  2004cited by this paper
• Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-like gene-1 signaling pathway via the activation of dopamine receptors.

  2004cited by this paper
• Imaging of dopamine transporters and D2 receptors in patients with Parkinson’s disease and multiple system atrophy

  2004cited by this paper
• Hypoxia/Ischemia Modulates G Protein–Coupled Receptor Kinase 2 and &bgr;-Arrestin-1 Levels in the Neonatal Rat Brain

  2004cited by this paper
• Effects of long‐term treatment with dopamine receptor agonists and antagonists on terminal arbor size

  2002cited by this paper
• Extracellular signal‐regulated kinases control expression of G protein‐coupled receptor kinase 2 (GRK2)

  2002cited by this paper
• The role of dopamine receptors in regulating the size of axonal arbors.

  2001cited by this paper
• Activation of Extracellular Signal-Regulated Protein Kinases Is Associated with a Sensitized Locomotor Response to D2Dopamine Receptor Stimulation in Unilateral 6-Hydroxydopamine-Lesioned Rats

  2000cited by this paper
• Serum S-100B protein in severe head injury.

  2000cited by this paper
• Serum S-100B protein in severe head injury.

  2000cited by this paper
• Dynamin and rab5 regulate GRK2-dependent internalization of dopamine D2 receptors.

  1999cited by this paper
• Rapid desensitization of PC12 cells stimulated with high concentrations of extracellular S100.

  1999cited by this paper
• G protein-coupled receptor kinases.

  1998cited by this paper
• Calcium and S100B Regulation of p53-Dependent Cell Growth Arrest and Apoptosis

  1998cited by this paper
• Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease

  1997cited by this paper
• S-100beta stimulates neurite outgrowth in the rat sciatic nerve grafted with acellular muscle transplants.

  1997cited by this paper
• S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction.

  1997cited by this paper
• S100β Stimulates Inducible Nitric Oxide Synthase Activity and mRNA Levels in Rat Cortical Astrocytes (*)

  1996cited by this paper
• Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases (*)

  1996cited by this paper
• Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.

  1996cited by this paper
• The S100 protein family: history, function, and expression.

  1995cited by this paper
• The functional anatomy of disorders of the basal ganglia.

  1995cited by this paper
• Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors

  1995cited by this paper
• Serotonin Uptake Sites and Serotonin Receptors Are Altered in the Limbic System of Schizophrenics

  1993cited by this paper
• Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.

  1993cited by this paper
• PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model.

  1991cited by this paper
• S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor.

  1990cited by this paper
• D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.

  1990cited by this paper

• Triptolide exposure triggers ovarian inflammation by activating cGAS-STING pathway and decrease oocyte quality in mouse.

  2024cites this paper
• Recent Advance of S100B Proteins in Spontaneous Intracerebral Hemorrhage and Aneurysmal Subarachnoid Hemorrhage.

  2024cites this paper
• The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker

  2023cites this paper
• Pathophysiology and Neuroimmune Interactions Underlying Parkinson’s Disease and Traumatic Brain Injury

  2023cites this paper
• A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology

  2022cites this paper
• Insights Into the Role of Platelet-Derived Growth Factors: Implications for Parkinson’s Disease Pathogenesis and Treatment

  2022cites this paper
• Nanotechnological approaches for pentamidine delivery

  2022cites this paper
• Extracellular S100B inhibits A‐type voltage‐gated potassium currents and increases L‐type voltage‐gated calcium channel activity in dopaminergic neurons

  2022cites this paper
• Extracellular S100B alters spontaneous Ca2+ fluxes in dopaminergic neurons via L-type voltage gated calcium channels: Implications for Parkinson’s disease

  2021cites this paper
• Growing role of S100B protein as a putative therapeutic target for neurological -and nonneurological- disorders.

  2021cites this paper
• Mechanism of Zn2+ and Ca2+ Binding to Human S100A1

  2021cites this paper
• S100B is selectively expressed by gray matter protoplasmic astrocytes and myelinating oligodendrocytes in the developing CNS

  2021cites this paper
• Beyond the GFAP-Astrocyte Protein Markers in the Brain

  2021cites this paper
• G protein‐coupled receptor kinases are associated with Alzheimer's disease pathology

  2021cites this paper
• S100B protein: general characteristics and pathophysiological implications in the Central Nervous System

  2020cites this paper
• Emerging role of S100B protein implication in Parkinson’s disease pathogenesis

  2020cites this paper
• The Zn2+ and Ca2+‐binding S100B and S100A1 proteins: beyond the myths

  2020cites this paper
• Studies on the Etiology of Parkinson’s disease

  2020cites this paper
• NDT_A_197032 1381..1402

  2019cites this paper
• Plasma levels of glial cell marker S100B in children with autism.

  2019cites this paper
• inPentasomes: An innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice.

  2019cites this paper
• Monitoring Interactions Between S100B and the Dopamine D2 Receptor Using NMR Spectroscopy.

  2019cites this paper
• L‐alpha‐aminoadipic acid restricts dopaminergic neurodegeneration and motor deficits in an inflammatory model of Parkinson’s disease in male rats

  2019cites this paper
• Vascular cognitive impairment: pathophysiological mechanisms, insights into structural basis, and perspectives in specific treatments

  2019cites this paper
• S100 Proteins in Atherosclerosis.

  2019cites this paper
• Glycomic and Proteomic Changes in Aging Brain Nigrostriatal Pathway*

  2018cites this paper
• Structural Basis for S100B Interaction with its Target Proteins

  2018cites this paper
• Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson’s disease: ex vivo and in vitro studies

  2018cites this paper
• The S100B story: from biomarker to active factor in neural injury

  2018cites this paper
• S100B polymorphisms are associated with age of onset of Parkinson’s disease

  2018cites this paper
• Current neurological investigations : Advantages and limits of routinely used approaches and techniques

  2017cites this paper
• Intra-generational protein malnutrition impairs temporal astrogenesis in rat brain

  2017cites this paper
• Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases.

  2016cites this paper
• Calbindin D28k and S100B have a similar interaction site with the lithium-inhibitable enzyme inositol monophosphatase-1: a new drug target site.

  2015cites this paper
• Motor coordination dysfunction induced by gold nanorods core/silver shell nanostructures in mice: disruption in mitochondrial transport and neurotransmitter release

  2014cites this paper
• Normal Cerebellar Development in S100B-Deficient Mice

  2014cites this paper
• Effects of tetrahydroxystilbene glucoside on behavior and dopaminergic neurons in 1鄄methyl鄄4鄄phenyl鄄1, 2, 3, 6鄄tetrahydropyridine鄄induced model mice

  2014cites this paper
• Avaliação temporal da expressão gênica e proteica de S100b no encéfalo de ratos neonatos submetidos à anóxia.

  2014cites this paper
• S100A9 Knockout Decreases the Memory Impairment and Neuropathology in Crossbreed Mice of Tg2576 and S100A9 Knockout Mice Model

  2014cites this paper
• Neurodevelopmental and cognitive behavior of glutaryl-CoA dehydrogenase deficient knockout mice.

  2013cites this paper
• Levels of S100B are raised in female patients with schizophrenia

  2013cites this paper
• Neuropathology and behavioral impairments in Wistar rats with a 6-OHDA lesion in the substantia nigra compacta and exposure to a static magnetic field

  2013cites this paper
• Da-Bu-Yin-Wan and Qian-Zheng-San, two traditional Chinese herbal formulas, up-regulate the expression of mitochondrial subunit NADH dehydrogenase 1 synergistically in the mice model of Parkinson's disease.

  2013cites this paper
• Genetic analysis of the S100B gene in Chinese patients with Parkinson disease.

  2013cites this paper
• Novel interactions of the TRTK12 peptide with S100 protein family members: specificity and thermodynamic characterization.

  2013cites this paper
• Functions of S100 proteins.

  2012cites this paper
• Thermodynamic and kinetic analysis of peptides derived from CapZ, NDR, p53, HDM2, and HDM4 binding to human S100B.

  2012cites this paper
• The S100B protein in biological fluids: more than a lifelong biomarker of brain distress

  2012cites this paper
• The Reference Level of Serum S-100B Protein for Poor Prognosis in Patients with Intracranial Extracerebral Hematoma

  2011cites this paper
• Power of a Metabonomic Approach to Investigate an Unknown Nervous Disease

  2011cites this paper